Rheumatology 2002; 41: 228-229
© 2002 British Society for Rheumatology
Paediatric Rheumatology |
Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis
Paediatric Rheumatology/Series Editor: P. Woo
Departments of
1 Paediatrics and
2 Physical Therapy, Leiden University Medical Centre and Departments of
3 Paediatrics and
4 Physical Therapy, University Hospital Rotterdam/Sophia's Children's Hospital, The Netherlands
Letter to the Editor
SIR, Systemic juvenile idiopathic arthritis (sJIA) is a difficult disease to treat. Drugs that can be effective, such as steroids and methotrexate (MTX), often lead to complications. Some patients are truly therapy-resistant, meaning that the combination of non-steroidal anti-inflammatory drugs (NSAIDs), steroids, MTX up to 1 mg/kg/week and cyclosporin A (CyA) (5 mg/kg/day) [1] fails to induce remission or
Notes
References